Radiopharm Theranostics Ltd valuation reiterated by Diamond Equity Research following progress in clinical trial
Radiopharm Theranostics Ltd (ASX:RAD) has received an update note from Diamond Equity Research following the approval of its Investigational New Drug...
Source: proactiveinvestors.com.au